Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study of S-309309 in Obese Adults

ClinicalTrials.gov ID: NCT05925114

Public ClinicalTrials.gov record NCT05925114. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Assess the Safety and Efficacy of S-309309 in Obese Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to understand the efficacy of S-309309 on the body weight of obese adults.

Study identification

NCT ID
NCT05925114
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shionogi
Industry
Enrollment
365 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 21, 2023 (Actual)
Primary completion
Apr 15, 2024 (Actual)
Completion
May 17, 2024 (Actual)
Last update posted
Apr 16, 2025

2023 – 2024

United States locations

U.S. sites
49
U.S. states
20
U.S. cities
43
Facility City State ZIP Site status
Flourish Research - Birmingham - PPDS Birmingham Alabama 35205-1605 —
Synexus Clinical Research Birmingham Alabama 35211-1320 —
Foothills Research Center - CCT - PPDS Phoenix Arizona 85044-6097 —
National Research Institute - ClinEdge - PPDS Los Angeles California 90057-3550 —
Catalina Research Institute Montclair California 91763-2231 —
Northern California Research Corp Sacramento California 95821-2640 —
Encompass Clinical Research - ClinEdge - PPDS Spring Valley California 91978-1522 —
Chase Medical Research LLC Waterbury Connecticut 06708-3346 —
A G A Clininical Trials- HyperCore PPDS Hialeah Florida 33012-3407 —
Westside Center for Clinical Research - ERN - PPDS Jacksonville Florida 32205-4785 —
3Sync, LLC Lake Worth Florida 33460-4400 —
Suncoast Research Group LLC - Flourish - PPDS Miami Florida 33135-1687 —
Angels Clinical Research Institute-Miami Miami Lakes Florida 33016-1598 —
Oviedo Medical Research - ClinEdge PPDs Oviedo Florida 32765-4515 —
Precision Clinical Research Sunrise Florida 333351-7311 —
Endocrine Consultants Research - Columbus - Centricity Research - HyperCore - PPDS Columbus Georgia 31904-4501 —
Javara, Inc./Privia Medical Group Georgia, LLC - Fayetteville - Javara - PPDS Fayetteville Georgia 302140-1578 —
Lifeline Primary Care - CCT-PPDS Lilburn Georgia 30047 —
Flourish Research - Ravenswood - PPDS Chicago Illinois 60640-7927 —
L MARC Research Center Louisville Kentucky 40213-1014 —
Annapolis Internal Medicine, LLC Annapolis Maryland 21401-7050 —
Privia Medical Group Mid-Atlantic - Javara - PPDS Silver Spring Maryland 20901-4402 —
Boston Clinical Trials Inc. - Alcanza - HyperCore - PPDS Boston Massachusetts 02131-2515 —
ActivMed Practices & Research, Inc. - Portsmouth - Alcanza - HyperCore - PPDS Methuen Massachusetts 01844 —
Be Well Clinical Studies LLC Lincoln Nebraska 68516 —
Palm Research Center, Inc Las Vegas Nevada 89148-5613 —
Tryon Medical Practice - Ballantyne - Javara - PPDS Charlotte North Carolina 28287-3884 —
Lucas Research - Hickory - HyperCore - PPDS Hickory North Carolina 28601-3829 —
AES - DRS - Synexus Clinical Research US, Inc. Akron Ohio 44311-1012 —
Velocity Clinical Research (Cincinnati - Ohio) - PPDS Cincinnati Ohio 45219-2975 —
Lynn Institute of East Oklahoma - ERN PPDS Oklahoma City Oklahoma 73104-5033 —
Hatboro Medical Associates PC Hatboro Pennsylvania 19040-2024 —
Medical Care, LLC Elizabethton Tennessee 47643-2654 —
Dallas Diabetes Research Center Dallas Texas 75230-6885 —
Helios CR Ins Houston - PPDS Houston Texas 77008-1366 —
Juno Research LLC Houston Texas 77040-5063 —
Juno Research LLC Houston Texas 77054 —
Edrocrine and Psychiatry Center Houston Texas 77095-2856 —
Helios CR, Inc. - Keller - PPDS Keller Texas 76248-4235 —
Vytalus Medical Group Kingwood Texas 77339 —
Flourish Research San Antonio Texas 78229-3539 —
Diabetes and Gandular Disease Clinic, PA San Antonio Texas 78229-4801 —
Consano Clinical Research San Antonio Texas 78258-3916 —
AES - DRS - Synexus Clinical Research US, Inc Murray Utah 84123-2967 —
Ogden Clinic - Grand View Roy Utah 84067-9438 —
Olympus Family Medicine - CCT - PPDS Salt Lake City Utah 84117 —
South Ogden Family Medicine South Ogden Utah 84405 —
Charlottesville Medical Research Center Charlottesville Virginia 22911-3589 —
Manasas Clinical Research Center Manassas Virginia 20110 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05925114, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05925114 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →